CME
Treatment of CLL/SLL with BTKis: Whole Patient Approaches
Host: Lindsey Roeker, MD The disease continuum for chronic lymphocytic leukemia (CLL) has rapidly evolved to include non-chemotherapy-based regimens that disrupt B cell receptor signaling. The increased availability of active treatment regimens along